Cresco Labs (OTCMKTS:CRLBF – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued to clients and investors on Tuesday, Zacks reports.
Separately, Alliance Global Partners reissued a “buy” rating on shares of Cresco Labs in a research note on Thursday, August 6th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.
Check Out Our Latest Report on Cresco Labs
Cresco Labs Trading Up 0.7%
Cresco Labs (OTCMKTS:CRLBF – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.06. Cresco Labs had a negative net margin of 15.50% and a negative return on equity of 7.53%. The company had revenue of $173.34 million during the quarter, compared to analysts’ expectations of $166.20 million. As a group, analysts predict that Cresco Labs will post -0.04 earnings per share for the current fiscal year.
About Cresco Labs
Cresco Labs Inc is a vertically integrated cannabis company headquartered in Chicago, Illinois. Founded in 2013, the company cultivates, manufactures and distributes cannabis products for adult-use and medical markets in states where cannabis is legally permitted.
The company’s product portfolio includes flower, pre-rolls, vapes, concentrates, edibles and other cannabis products sold under brands such as Cresco, High Supply, Good News, Wonder Wellness, FloraCal, Remedi and Mindy’s Edibles.
See Also
- Five stocks we like better than Cresco Labs
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.
